Three members of one family who presented in adult life with pseudohypoparathyroidism are reported. The importance of screening members of the family of patients with pseudohypoparathyroidism is stressed. Higher doses of In-hydroxycholecalciferol are required than in idiopathic or surgical hypoparathyroidism or in chronic renal failure.
Introduction
Pseudohypoparathyroidism, first described by Albright et al. (1942) , is a rare hereditary disorder characterized by resistance to the action of parathyroid hormone. Clinical features include short stature, round face, obesity, and subnormal intelligence. The diagnosis may be made by the presence of hypocalcaemia, hyperphosphataemia, elevated serum parathyroid hormone, and a reduced cyclic adenosine-3',5'-monophosphate (cAMP) response to exogenous parathyroid hormone administration. In the 'complete' syndrome (Type Ia, Brickman et al. 1977) , there is no radiological evidence of hyperparathyroidism despite elevated levels of parathyroid hormone, indicating both renal and bone end-organ refractoriness to the hormone. Reported here are three related individuals with pseudohypoparathyroidism Type Ia in whom the diagnosis was delayed until adult life.
Case reports
Case 1: A 54-year-old woman presented in 1979 with a three-week history ofparaesthesiae in her arms and legs. In October 1962 thyrotoxicosis had been diagnosed and treatment commenced with carbimazole. In March 1963 subtotal thyroidectomy was performed: histology showed thyroid hyperplasia. Hypothyroidism was diagnosed in 1976 and treatment with thyroxine started. In 1968 she had carpopedal spasm and the serum calcium was found to be 1.75 mmol/l (normal range 2.25-2.65).
On examination she was plump with a round face, measured 1.54 metres in height and was of average intelligence. Biochemical investigations (Table 1 ) and the severly impaired response of urinary cAMP to the infusion of parathyroid hormone (Figure 1) confirmed the diagnosis of pseudohypoparathyroidism. Radiographs of the skull and hands showed no developmental abnormality or osteitis fibrosa. After witholding replacement thyroxine therapy for two weeks, her serum thyroxine was 41 nmolfl (normal 50-150) and serum thyrotropin-stimulating hormone (TSH) 19 miu/l (normal 0-7). Treatment was commenced with la-hydroxycholecalciferol (laOHD 3 ) . The patient is at present taking 4 J.1g laOHD 3 daily, and her serum calcium is 1.86 mmol/l. Case 2: The 30-year-old daughter of Case I was seen when members of the family were screened ( Figure 2 ) for pseudohypoparathyroidism; she was asymptomatic. However, she gave a history of carpal spasm one year previously. She was plump, round faced, measured 1.52metres in height and was of normal intelligence. Biochemical investigations (Table I) Case 3: The 19-year-old daughter of Case 1 presented in 1979 with a six-month history of paraesthesiae in arms and legs. On examination she was plump, round faced, measured 1.53 metres in height and was of normal intelligence. Biochemical investigations ( Table 1 ) and impaired cAMP response to parathyroid hormone infusion (Figure 1 )confirmed the diagnosis of pseudohypoparathyroidism. X-rays of the skull and the hands were normal. Although the serum thyroxine was elevated ( Table 1 ) the free thyroxine index was normal (127 nmol/l; normal range 40-140). She is currently taking 41lg laOHD 3 daily and her serum calcium is 1.86 mmol/l.
Discussion
The average age of onset of symptoms in pseudohypoparathyroidism is about 8 years and of diagnosis some 10 years later (Bronsky et al. 1958) . However, patients with pseudohypoparathyroidism may have relatively few symptoms and diagnosis might therefore be delayed until adult life. Four of the 9 patients with pseudohypoparathyroidism described by Lewin et al. (1978) were over the age of 30 years. Although pseudohypoparathyroidism is rare, the diagnosis must be considered in patients presenting with carpopedal spasm and paraesthesiae due to hypocalcaemia. There have been several reports of families with pseudohypoparathyroidism (Lee et al. 1968 , Kinard et al. 1979 ). Mann et al. (1962 suggested a X-linked dominant inheritance with variable penetrance, but a recent study (Kinard et al. 1979) suggested an autosomal dominant inheritance. Despite this, a positive family history was present in only one of the 9 patients described by Lewin et al. (1978) . If pseudohypoparathyroidism is diagnosed then related members should be screened, with estimation of serum calcium, to detect any other members of the family with the condition. Although only 3 members of the present family have been discovered to have pseudohypoparathyroidism, it remains unproven whether the 16-year-old boy who died from 'asthma' might indeed have had laryngeal stridor secondary to hypocalcaemia. In addition, the female infant who died at 4 months of 'cot-death' might have had a hypocalcaemic fit.
Hypothyroidism has been found in association with pseudohypoparathyroidism and this may be due to isolated thyrotropin deficiency (Lee et al. 1968 , Zisman et al. 1969 . In Case 1 it is likely that the hypothyroidism was secondary to thyroid disease in view of the elevated levels of TSH and her previous history of subtotal thyroidectomy for thyrotoxicosis.
Abnormalities of vitamin D metabolism have recently been reported in patients with pseudohypoparathyroidism: levels of 1,25-dihydroxycholecalciferol may be low (Drezner et al. 1976) . Moreover, administration of 1,25-dihydroxycholecalciferol to patients with pseudohypoparathyroidism restores a normal calcaemic response to parathyroid hormone. The sole defect, however, in pseudohypoparathyroidism is unlikely to be due to abnormal vitamin D metabolism since, with the correction of serum calcium to normal, urinary cAMP responses to administered parathyroid hormone remain impaired.
It is now generally agreed that treatment with lc-hydroxycholecalclferol is the treatment of choice (Kovarik et al. 1979) . Larger doses of lcxOHD 3 are required in pseudohypoparathyroidism than in idiopathic or surgical hypoparathyroidism or in chronic renal failure (Brickman et al. 1977) .
